Abstract:Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions.Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis.Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis.Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. Brief Description of the Purpose of the StudyTo investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. To investigate the clinical value and security of contrast enhanced ultrasound (CEUS) guided biopsy for diagnosis of pancreatic lesions. Methods49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. 49 patients with 50 pancreatic lesions which could not be guided clearly by conventional ultrasound received CEUS guided biopsy using 18 Gauge needle. Satisfactory sampling was defined as the acquired tissues which were large enough to give a definite diagnosis. Pathological diagnosis or follow-up (at least 6 months) were taken as the final diagnosis. Main ResultsBiopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Biopsy of this group had a success rate of 98.0% with the mean puncture times of 2. 8. Qualitative diagnosis was obtained in 47 of 49 cases, resulted a qualitative diagnosis rate of 95.9% (47/ 49). 46 of 47 cases were corresponding to the final diagnosis and the coincidence rate was 97.9% (46/47). The sensitivity and specificity of biopsy was 97.9% and 100% respectively. Complications occurred in 1 case (2%) of biliary peritonitis. Importance of the ConclusionsFor pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions. For pancreatic lesions which could not be clearly guided by conventional ultrasound, CEUS guided percutaneous biopsy could not only improve the accuracy and sensitivity, but increase the success and effective rate of puncture. With lower incidence of complication and better security, CEUS guided biopsy is an effective method in characterizing pancreatic lesions.

Clinical and Technical Guideline for Endoscopic Ultrasound (EUS)-Guided Tissue Acquisition of Pancreatic Solid Tumor: Korean Society of Gastrointestinal Endoscopy (KSGE)

Consensus statements on endoscopic ultrasound‐guided tissue acquisition. Guidelines from the Asian Endoscopic Ultrasound Group

American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis and management of solid pancreatic masses: summary and recommendations

Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated January 2017

Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – March 2017

Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline

Diagnosis of Pancreatic Solid Lesions, Subepithelial Lesions, and Lymph Nodes Using Endoscopic Ultrasound

Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer

Cutting edge of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesions

Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches

Position statement on EUS-guided ablation of pancreatic cystic neoplasms from an international expert panel

Guidance and Control of Percutaneous Biopsy in Pancreatic Lesions with Contrast Enhanced Ultrasound

III BRAZILIAN CONSENSUS STATEMENT ON ENDOSCOPIC ULTRASOUND

Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel

Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling

Endoscopic Ultrasound-Guided Oncologic Therapy for Pancreatic Cancer

Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis

Endoscopicultrasonography guided treatment of gastric biopsy specimens of high grade intraepithelial neoplasia

Diagnostic Endoscopic Ultrasound: Technique, Current Status and Future Directions